ADRX stock news

ADRX stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-20 14:16:00 UTC#487030newconfirmednews

TD Cowen initiates coverage of ADARx Pharmaceuticals (ADRX) with Buy rating

dow_jonesimportance 0.30trust 0.70ADARx Pharmaceuticals, Inc. +0.30TD Cowen +0.30

2026-10-20 12:58:00 UTC#486531newconfirmednews

JP Morgan initiates ADARx Pharmaceuticals (ADRX) at Overweight with $38 price target

dow_jonesimportance 0.40trust 0.70ADARx Pharmaceuticals, Inc. +0.40JPMorgan Chase & Co. +0.40

2026-10-20 12:36:00 UTC#486422newconfirmednews

UBS initiates coverage of ADARx Pharmaceuticals with Buy rating

dow_jonesimportance 0.30trust 0.70ADARx Pharmaceuticals, Inc. +0.40UBS Group AG +0.40

2026-10-02 21:46:00 UTC#407527newconfirmednews

OrbiMed Advisors discloses 14.0% stake in ADARx Pharmaceuticals following recent IPO

tradingviewimportance 0.40trust 0.80OrbiMed Advisors LLC +0.30ADARx Pharmaceuticals, Inc. +0.30

2026-09-28 19:39:16 UTC#379882newconfirmednews

ADARx Pharmaceuticals Files for $1.74B IPO, Secures $100M Private Placement from AbbVie

yahooimportance 0.50trust 0.70ADARx Pharmaceuticals, Inc. +0.40AbbVie Inc. +0.30Nasdaq, Inc. 0

2026-09-25 21:25:03 UTC#371162duplicateconfirmednews

ADARx Pharmaceuticals shares rise 30% following $446.3 million upsized IPO

bloombergimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.50

2026-09-25 16:21:24 UTC#369923newconfirmednews

ADARx Pharmaceuticals shares jump 30% to $22.10 in Nasdaq market debut following $446.3M upsized IPO

reutersimportance 0.50trust 0.90ADARx Pharmaceuticals, Inc. +0.60City Therapeutics 0Iambic Therapeutics 0+2 entities

2026-09-25 11:04:10 UTC#368152duplicateconfirmednews

ADARx Pharmaceuticals completes $446.3 million upsized US IPO

reutersimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.30

2026-09-25 11:01:59 UTC#368142duplicateconfirmednews

ADARx Pharmaceuticals completes $446.3 million upsized US IPO at $17 per share

reutersimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.30City Therapeutics, Inc. 0Iambic Therapeutics, Inc. 0+2 entities

2026-09-25 03:15:05 UTC#366555duplicateconfirmednews

ADARx Pharmaceuticals raises $446.3 million in upsized IPO at top of range

bloombergimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.30

2026-09-24 23:43:53 UTC#366145duplicateconfirmednews

ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

bloombergimportance 0.40trust 0.90ADARx Pharmaceuticals, Inc. +0.30

2026-09-24 23:39:00 UTC#366069duplicateconfirmednews

ADARx Pharmaceuticals prices 26.3 million share IPO at $17 per share

dow_jonesimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.20

2026-09-24 23:34:48 UTC#366052newconfirmednews

ADARx Pharmaceuticals prices upsized $446.3 million IPO at $17 per share

reutersimportance 0.60trust 0.90ADARx Pharmaceuticals, Inc. +0.20

2026-09-22 07:15:23 UTC#347026newconfirmednews

AbbVie discloses $600M China asset payment, faces House inquiry on clinical trials, and invests in ADARx IPO

tradingviewimportance 0.60trust 0.60AbbVie Inc. -0.20ADARx Pharmaceuticals, Inc. +0.30Iambic Therapeutics +0.30+1 entities

2026-09-21 17:00:20 UTC#344098duplicateconfirmednews

ADARx Pharmaceuticals seeks up to $371.9 million in US IPO

bloombergimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.20

2026-09-21 11:17:00 UTC#341821updateconfirmednews

ADARx Pharmaceuticals sets IPO price range at $15-$17 per share for 21.9 million share offering

dow_jonesimportance 0.60trust 0.90ADARx Pharmaceuticals, Inc. +0.30AbbVie Inc. +0.40

2026-09-21 10:35:44 UTC#341592updatereportednews

ADARx Pharmaceuticals targets $1.74 billion valuation in upcoming U.S. IPO, Reuters reports

reutersimportance 0.40trust 0.80ADARx Pharmaceuticals, Inc. +0.30

2026-09-21 10:13:59 UTC#341457newconfirmednews

ADARx Pharmaceuticals files for U.S. IPO seeking to raise up to $371.9 million

reutersimportance 0.40trust 0.90ADARx Pharmaceuticals, Inc. +0.20

2026-09-17 14:31:00 UTC#328232newforecastanalysis

DelveInsight Forecasts PNH Market Growth Through 2036 Driven by Five Emerging Therapies

yahooimportance 0.30trust 0.50Regeneron Pharmaceuticals, Inc. +0.30Novo Nordisk A/S +0.30NovelMed Therapeutics +0.30+2 entities

2026-09-04 22:15:00 UTC#270704duplicateconfirmednews

ADARx Pharmaceuticals files for Nasdaq IPO under ticker ADRX

dow_jonesimportance 0.30trust 0.90ADARx Pharmaceuticals, Inc. +0.10Nasdaq, Inc. 0U.S. Securities and Exchange Commission 0